Olema furnishes investor presentation at SABCS; no specific data disclosed

Olema Pharmaceuticals, Inc.

Investor presentation dated December 6, 2023 made available on company website.
Presentation exhibited as Exhibit 99.1 but full content not included in filing text.
No financial results, clinical data updates, or guidance changes referenced in the 8-K.

item 7.01 item 9.01

Olema Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-068439

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.